We are live on ! Find out more

1,924 hedge funds and large institutions have $130B invested in Merck in 2017 Q3 according to their latest regulatory filings, with 78 funds opening new positions, 794 increasing their positions, 802 reducing their positions, and 67 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more call options, than puts

Call options by funds: $1.4B | Put options by funds: $1.05B

16% more first-time investments, than exits

New positions opened: 78 | Existing positions closed: 67

0.69% more ownership

Funds ownership: 77.61%78.3% (+0.69%)

0% more capital invested

Capital invested by funds: $130B → $130B (+$640M)

0% less funds holding

Funds holding: 1,9261,924 (-2)

1% less repeat investments, than reductions

Existing positions increased: 794 | Existing positions reduced: 802

15% less funds holding in top 10

Funds holding in top 10: 138117 (-21)

Holders
1,924
Holders Change
-2
Holders Change %
-0.1%
% of All Funds
47.96%
Holding in Top 10
117
Holding in Top 10 Change
-21
Holding in Top 10 Change %
-15.22%
% of All Funds
2.92%
New
78
Increased
794
Reduced
802
Closed
67
Calls
$1.4B
Puts
$1.05B
Net Calls
+$342M
Net Calls Change
-$259M
Name Holding Trade Value Shares
Change
Change in
Stake
HighTower Advisors
151
HighTower Advisors
Illinois
$104M +$2.81M +46,315 +3%
AG
152
Aperio Group
California
$104M +$2.3M +37,888 +2%
State of Tennessee, Department of Treasury
153
State of Tennessee, Department of Treasury
Tennessee
$103M +$6.48M +106,844 +7%
EPFB
154
Employees Provident Fund Board
Malaysia
$103M +$16.7M +274,656 +19%
BIP
155
Brandes Investment Partners
California
$102M -$37.6M -619,642 -27%
MHI
156
Miller Howard Investments
New York
$101M -$2.94M -48,509 -3%
Los Angeles Capital Management
157
Los Angeles Capital Management
California
$98.3M +$9.44M +155,742 +11%
VAM
158
ValueInvest Asset Management
Luxembourg
$98M -$4.85M -79,963 -5%
GIA
159
Gateway Investment Advisers
Ohio
$97.5M -$371K -6,118 -0.4%
Pzena Investment Management
160
Pzena Investment Management
New York
$97.3M +$44.2M +728,380 +84%
H
161
Hexavest
Quebec, Canada
$97.2M +$1.63M +26,951 +2%
Two Sigma Advisers
162
Two Sigma Advisers
New York
$97M +$32.9M +543,230 +52%
CB
163
Commerce Bank
Missouri
$95.2M +$5.71M +94,240 +6%
TCM
164
Tekla Capital Management
Massachusetts
$94.3M
Capital Fund Management (CFM)
165
Capital Fund Management (CFM)
France
$93.7M -$23.1M -380,738 -20%
BNP Paribas Asset Management
166
BNP Paribas Asset Management
France
$93.1M -$4.67M -77,070 -5%
SCM
167
Sterling Capital Management
North Carolina
$92.2M -$91.8K -1,515 -0.1%
GC
168
Guggenheim Capital
Illinois
$89.8M +$1.17M +19,308 +1%
ACI
169
AMP Capital Investors
Australia
$87.6M +$983K +16,206 +1%
CIC
170
Crawford Investment Counsel
Georgia
$86.4M +$3M +49,409 +4%
SC
171
SRB Corp
Massachusetts
$85.9M
ZIM
172
Zacks Investment Management
Illinois
$85.6M +$657K +10,836 +0.8%
MLICM
173
Metropolitan Life Insurance Company (MetLife)
New York
$83.3M -$1.48M -24,416 -2%
Axa
174
Axa
France
$81.1M +$317K +5,227 +0.4%
FWCM
175
Ferguson Wellman Capital Management
Oregon
$79.6M +$3.28M +54,038 +4%

MRK Hedge Fund Activity: Q3 2017 in Review

1,924 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2017, worth a combined $130B — up 0.49% from $130B a quarter earlier.

Buyers outnumbered sellers: 78 funds opened new MRK positions and 67 closed out — a net gain of 11 holders — while 794 added to existing stakes and 802 trimmed.

The largest buyer was Bank of America, adding an estimated $451M. The largest seller was Capital World Investors, cutting an estimated $413M.

  • 1,924 institutional investors held Merck (MRK) as of Q3 2017, down from 1,926 in Q2 2017.
  • Funds reported $130B of Merck stock for Q3 2017, up 0.49% quarter-over-quarter.
  • 78 funds opened new Merck positions in Q3 2017 and 67 closed out, a net change of +11 holders.
  • The largest Merck buyer in Q3 2017 was Bank of America, an estimated $451M added.
  • The largest Merck seller in Q3 2017 was Capital World Investors, an estimated $413M sold.

Based on aggregated 13F filings for Q3 2017.